Page 65 | Certara

Publication

pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization

Dr. Mark Sale, Dr. Keith Nieforth, James Craig and peers from industry, healthcare, and academia…

CertaraJune 28, 2024

On-Demand Webinar

How AI-powered writing software can bring a benefit in Japan [Japan Webinar]

This webinar will be held in Japanese only. Medical writing is a critical part of…

CertaraJune 27, 2024

On-Demand Webinar

Catalyzing DMTA Information into Insights

Drug discovery is a data-driven research process that requires accurate data capture, ample and reliable…

CertaraJune 27, 2024

Blog

Future Clinical Study Design: CDISC, FHIR, OMOP, or Hybrid Model?

June 27, 2024 Advances in technology and changes to the regulatory environment have resulted in…

CertaraJune 27, 2024

Publication

Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain

CertaraJune 26, 2024

Press Coverage

Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database

CertaraJune 26, 2024

Blog

Generative AI Tools for Regulatory Writing

Regulatory writing is a crucial component of the drug development process. Regulatory writers must understand…

CertaraJune 20, 2024

On-Demand Webinar

RAPS Sponsored Webcast: Author Clinical Study Reports with Data Privacy & Disclosure in Mind

EMA Policy 0070 is a main driver for clinical trial data anonymization. This regulation requires…

CertaraJune 19, 2024

Blog

ICH M12 Guidelines & Your Drug-Drug Interaction Package

We have provided an overview of the key changes to the ICH M12 drug-drug interaction…

CertaraJune 19, 2024

Case Study

Case Study. Enhancing HEOR Global Knowledge Sharing

The Global Health Economics and Outcomes Research (HEOR) team of a leading global healthcare company…

CertaraJune 19, 2024

pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization

How AI-powered writing software can bring a benefit in Japan [Japan Webinar]

Catalyzing DMTA Information into Insights

Future Clinical Study Design: CDISC, FHIR, OMOP, or Hybrid Model?

Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain

Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database

Generative AI Tools for Regulatory Writing

RAPS Sponsored Webcast: Author Clinical Study Reports with Data Privacy & Disclosure in Mind

ICH M12 Guidelines & Your Drug-Drug Interaction Package

Case Study. Enhancing HEOR Global Knowledge Sharing

Newsletter sign up

Quick links

Solutions

Contact